<DOC>
	<DOC>NCT02583958</DOC>
	<brief_summary>Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a European, randomised clinical trial.</brief_summary>
	<brief_title>Assessment of Efficacy &amp; Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Patient over 18 years old who has provided his/her written informed consent, Patient who can be monitored by the same investigation team throughout the whole duration of the study, Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing, Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3, Ulcer area &gt; or equal to 5cm2, Ulcer duration &gt; or equal to 6 months, Ulcer presenting a the surface wound bed covered with 50% or more by sloughy tissue, Moderately or heavily exudative ulcers. Clinical infection on the wound bed.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>